Delaying Bone Drugs After Cancer Spreads to Bone Nearly Doubles Fracture Risk, Study Finds
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine